loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X

List of chemical intermediates, fine chemicals supplied/manufactured by Porton Pharma Solutions

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 (1R,2R)-2-amino-6-(4-nitrophenyl)-1-phenylhex-5- yn-1-olhydrochloride (1)

02 (1R,5S)-3-ethylbicyclo[3.2.0]hept-3- en-6-one (1)

03 (2-(((1-chloroethoxy)carbonyl)(met hyl)amino)pyridin-3- yl)methyl N-(tert-butoxycarbonyl)-N-methylglycinate (1)

04 (2-(methylamino)pyridin-3- yl)methyl 2-(tertbutoxycarbonyl(methyl)amino)acet ate (1)

05 (2-chloro-5-iodophenyl)(4- fluorophenyl)methanone (1)

06 (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy- 2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide (1)

07 (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4- chloro-3-(4- ethoxybenzyl)phenyl)tetrah ydro-2H-pyran-3,4,5-triyltriacetate (1)

08 (2R,3S)-2-(2,5-difluorophenyl)-3-methyl-2- [(1H-1,2,4-triazol-1-yl)- methyl]-oxirane (1)

09 (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6- ((triMethylsilyloxy)Methyl)t etrahydro-2H-pyran-2-one (1)

10 (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan (1)

11 (3S,5S,6R)-3-amino-6-methyl-5-phenyl-1-(2,2,2- trifluoroethyl)piperidin-2- one (1)

12 (3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2- trifluoroethyl)piperidine-3- aminium 4-nitrobenzoate (1)

13 (6S)-2'-oxo-1',2',5,7- tetrahydrospiro[cyclopenta[b]pyridi ne-6,3'-pyrrolo[2,3-b]pyridine]-3- carboxylic acid (1)

14 (6S)-4,6,7,8-tetrahydro-4- oxo-Pyrrolo[1,2- a]pyriMidine-6-carboxylic acid (1)

15 (S)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetra hydrofuran (1)

16 (S)-3-hydroxytetyrahydrofuran (5)

17 1-(1-methylpiperidin-4- yl)piperazine hydrochloride (1)

18 1-Methyl-4-(6- Aminopyridin-3- Yl)Piperazine (1)

19 2-((3bS,4aR)-5,5-difluoro-3- (trifluoromethyl)-3b,4,4a,5- tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic acid (1)

20 2-Amino-1,3-propanediol (1)

21 2-amino-N-(2,2,2-trifluoroethyl)acetamide hydrochloride (1)

22 2-oxo-1-(4-piperidinyl)-2,3- dihydro-1H-imidazo[4,5- b]pyridine dihydrochloride (1)

23 3-(piperidin-4-yl)quinolin-2(1H)-one hydrochloride (1)

24 4-(2-Bromoacetyl)benzonitrile (1)

25 4-amino-2-fluoro-N- methylbenzamide (1)

26 5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-amine (1)

27 5-bromo-2-chloro-4'- ethoxydiphenylmethane (1)

28 9-((triisopropylsilyl)oxy)-6,7,8,9- tetrahydro-5Hcyclohepta[b]pyridin-5-one hydrochloride (1)

29 Acetoxy Empagliflozin (1)

30 Methyl (2R)-2-amino-3-(7- methyl-1H-indazol-5- yl)propanoate dihydrochloride (1)

31 Methyl (3R)-3-(tert- butyldimethylsilyloxy)-5- oxo-6- triphenylphosphoranylidene hexanoate (1)

32 Moc-L-tert-Leucine (1)

33 Sodium(S)-4-oxo-4,6,7,8- tetrahydropyrrolo[1,2- a]pyrimidine-6-carboxylate (1)

34 trans-2-(4-acetamidocyclohexyl)acetic acid (1)

filter

01 Abemaciclib (1)

02 Afatinib (1)

03 Amprenavir (1)

04 Apalutamide (1)

05 Atazanavir (1)

06 Cariprazine Hydrochloride (1)

07 Dapagliflozin (2)

08 Empagliflozin (6)

09 Fluralaner (1)

10 Fosamprenavir (1)

11 Iopamidol (1)

12 Isavuconazonium Sulfate (5)

13 Lenacapavir (1)

14 Mirogabalin Besylate (1)

15 Radalbuvir (1)

16 Rimegepant Sulfate (2)

17 Rosuvastatin Calcium (1)

18 Trilaciclib (1)

19 Ubrogepant (3)

20 Vibegron (3)

21 Zavegepant HCl (3)

filter

01 1171331-39-7 (1)

02 1180002-01-0 (1)

03 1180132-17-5 (1)

04 1190363-45-1 (1)

05 1190392-22-3 (1)

06 1235479-61-4 (1)

07 1375470-88-4 (1)

08 1414976-14-9 (1)

09 1421271-01-3 (1)

10 1455358-16-3 (1)

11 1456803-37-4 (1)

12 147118-35-2 (1)

13 1620056-83-8 (1)

14 162537-11-3 (1)

15 1628836-08-7 (1)

16 20099-89-2 (1)

17 241479-73-2 (1)

18 2901-44-2 (1)

19 32384-65-9 (1)

20 338990-31-1 (1)

21 349535-15-5 (1)

22 368421-58-3 (1)

23 461432-23-5 (1)

24 461432-25-7 (1)

25 534-03-2 (1)

26 571189-49-6 (1)

27 781649-84-1 (1)

28 855778-84-6 (1)

29 86087-23-2 (5)

30 915087-25-1 (1)

31 915095-86-2 (1)

32 915095-89-5 (1)

33 915095-94-2 (1)

34 915095-99-7 (1)

1628836-08-7
Vibegron
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
1235479-61-4
Mirogabalin Besylate
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
338990-31-1
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
1180002-01-0
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
915095-86-2
Empagliflozin
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
368421-58-3
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
461432-25-7
Dapagliflozin
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
241479-73-2
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
32384-65-9
Empagliflozin
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
915095-94-2
Empagliflozin
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
Post Enquiry
POST ENQUIRY